| Name | Last Trade | | Change |
|---|
| BMY - NYQ | $24.46 | | 0.00 0.00% | BRISTOL-MYERS SQUIBB | - 1 YEAR CHART
- News
- [$$] Investors, Bewareat Barrons.com(Sat, Nov 21)
- UPDATE - FDA OKs Abilify for child autism irritabilityat Reuters(Fri, Nov 20)
- FDA OKs Abilify for autism-linked irritabilityAP(Fri, Nov 20)
- Sanofi-Aventis Falling Off a Patent Cliff?at CNBC(Fri, Nov 20)
- U.S. Food and Drug Administration Approves ABILIFYŽ (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)Business Wire(Fri, Nov 20)
- Big Pharma Mergers: Good News Or Bad?Investor's Business Daily(Fri, Nov 20)
- [$$] Bristol-Myers Faces Lower Salesat Barrons.com(Fri, Nov 20)
- Pozen Initiates Phase III on PA325/40Zacks.com(Fri, Nov 20)
- AstraZeneca Seeks FDA ApprovalZacks.com(Fri, Nov 20)
- Jim Cramer's Portfolios of the Weekat TheStreet.com(Fri, Nov 20)
- Competition in Blood-Thinners: Win-Win for Everyone Involvedat Seeking Alpha(Fri, Nov 20)
- Healthcare Spin Off Companies Offer Opportunity To Investors According To Credit Suisse Senior AnalystWall Street Transcript(Thu, Nov 19)
- UPDATE - Rio Tinto unit Cloud Peak IPO prices below rangeat Reuters(Thu, Nov 19)
- AstraZeneca Enters the Race for the Next Plavixat Minyanville.com(Thu, Nov 19)
|
|
